Phase III Study of a Topical Gel Formulation for Treatment and Prevention of Raynaud's Phenomenon
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this research study is to test the safety, tolerability, and effectiveness of
Topical AmphiMatrix with Nitroglycerin (MQX-503) to relieve Raynaud's symptoms and increase
blood flow to the fingers.